We are live on ! Find out more
RPTX

Repare Therapeutics

Delisted

RPTX was delisted on the 27th of January, 2026.

0 hedge funds and large institutions have $0 invested in Repare Therapeutics in 2026 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 45 closing their positions.

New
Increased
Maintained
Reduced
Closed

58.37% less ownership

Funds ownership: 58.37%0% (-58%)

100% less funds holding

Funds holding: 460 (-46)

100% less funds holding in top 10

Funds holding in top 10: 40 (-4)

100% less capital invested

Capital invested by funds: $65.4M → $0 (-$65.4M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 45

Holders
Holders Change
-46
Holders Change %
-100%
% of All Funds
Holding in Top 10
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-100%
% of All Funds
New
Increased
Reduced
Closed
45
Calls
Puts
Net Calls
Net Calls Change

RPTX Hedge Fund Activity: Q1 2026 in Review

0 of the 8,134 institutional investors tracked by Wall St. Rank reported a position in Repare Therapeutics (RPTX) for Q1 2026, worth a combined $0 — down 100% from $65.4M a quarter earlier.

Sellers outnumbered buyers: 45 funds closed out of RPTX and 0 opened new positions — a net loss of 45 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was BVF Inc, exiting entirely with an estimated $26.9M sold.

  • 0 institutional investors held Repare Therapeutics (RPTX) as of Q1 2026, down from 46 in Q4 2025.
  • Funds reported $0 of Repare Therapeutics stock for Q1 2026, down 100% quarter-over-quarter.
  • 0 funds opened new Repare Therapeutics positions in Q1 2026 and 45 closed out, a net change of -45 holders.
  • The largest Repare Therapeutics seller in Q1 2026 was BVF Inc, an estimated $26.9M sold.

Based on aggregated 13F filings for Q1 2026.